Shares of AbbVie were up Friday after the company reported a big jump in revenue. The drug maker said revenue rose to $6.45 billion, the increase driven by the demand for Humira. Earnings of $1.26 a share topped analysts’ predictions. The company expects full-year earnings in the range of $4.73 to $4.83 per share, which is higher than the previous guidance outlook. AbbVie shares have climbed more than 9% since the beginning of the year.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
